Neurology Advisor

Neurology Advisor provides health care professionals with comprehensive information and clinical news on the management of neurological conditions.

[Neurology Advisor @NeuroAdvisor]

Medicine is changing & so are we: more digital, more personalized & more resources. Your trusted source for the information you need, when you need it, is here with a new look & feel – see the all-new @NeuroAdvisor, part of the @HaymarketMedNet https://t.co/JX4XxxJnv6

[Neurology Advisor @NeuroAdvisor]

Women with #Parkinson disease have higher odds of Alzheimer disease-related amyloid plaque burden than men, but this greater neuropathologic burden was not associated with differences in Alzheimer #dementia rates or cognitive performance.

#ean2026

https://t.co/UQctBvnd06

[Neurology Advisor @NeuroAdvisor]

Among patients with treatment-resistant #ChronicMigraine, #eptinezumab was associated with sustained reductions in headache burden over up to 48 months, particularly in those who remained on treatment, despite declining long-term persistence.

https://t.co/xwOOEm5GhY

[Neurology Advisor @NeuroAdvisor]

#MultipleSclerosis was associated with effects on multiple social determinants of health, particularly social life and #employment, with greater burden among patients with socioeconomic disadvantage, comorbidities, and higher disability.

#ean2026

https://t.co/CGUbmLIlHw

[Neurology Advisor @NeuroAdvisor]

Digital sleep-wake #biomarkers derived from wearable accelerometers added predictive value to #dementia risk models, with contributions comparable to APOE ε4 genotype.

https://t.co/DCVQJBWwvI

[Neurology Advisor @NeuroAdvisor]

The Neurology Advisor team will deliver comprehensive reports from EAN 2026, held from June 27 to 30, in Geneva, Switzerland.

#ean2026 #neurology

https://t.co/pqbA9Umbku

[Neurology Advisor @NeuroAdvisor]

#Cannabinoids did not significantly improve motor symptoms, nonmotor symptoms, quality of life, anxiety, or depression among patients with #ParkinsonDisease, although a potential benefit signal for nonmotor symptoms was observed with nabilone.

https://t.co/jfB1Rnqal6

[Neurology Advisor @NeuroAdvisor]

#Ecopipam maintained clinically meaningful reductions in tic severity and reduced relapse risk for up to 24 weeks among children and adolescents with #TouretteSyndrome, supporting its potential as a novel treatment option.

https://t.co/9ItwX7d0to

[Neurology Advisor @NeuroAdvisor]

Among middle-aged and older adults, #migraine with aura, but not migraine overall or without aura, was associated with increased risk for incident #IschemicStroke, with the strongest associations observed in men younger than 72 years.

https://t.co/7CqWjBGOXa

[Neurology Advisor @NeuroAdvisor]

Non-White participants and participants with lower educational attainment had less access to technology used for remote #AlzheimerDisease research visits.

#HealthDisparities

https://t.co/DHOxeB6qbk

[Neurology Advisor @NeuroAdvisor]

Greater residential #GreenSpace exposure was associated with a lower risk for #neurodegenerative diseases among middle-aged and older adults, with the strongest association observed within a 250-meter residential buffer.

https://t.co/EF7P7phTAq

[Neurology Advisor @NeuroAdvisor]

Cerebrospinal fluid biomarkers associated with #AlzheimerDisease, particularly phosphorylated tau, were linked to #CognitiveImpairment in patients with #ALS.

https://t.co/voHzx0Dbzy

[Neurology Advisor @NeuroAdvisor]

Among patients undergoing endovascular #thrombectomy for acute ischemic #stroke, contact aspiration improved reperfusion outcomes compared with stent retrievers in women, but not in men.

https://t.co/KvDObpQhhC

[Neurology Advisor @NeuroAdvisor]

According to a meta-analysis of global population-based studies, the incidence and prevalence of #dementia with Lewy bodies increased with age, with a higher rate observed in men than in #women.

https://t.co/mxLwUBERPo

[Neurology Advisor @NeuroAdvisor]

Among patients with MS-related fatigue, amantadine, fampridine, and methylphenidate improved fatigue-related functioning, but no medication outperformed placebo for #fatigue severity.

#MultipleSclerosis

https://t.co/drVzeFANeX

[Neurology Advisor @NeuroAdvisor]

Higher #metabolomic age relative to chronological age was associated with increased risks for vascular, unspecified, and all-cause #dementia and earlier dementia onset among adults from the UK Biobank.

https://t.co/yVGWNmfvKS

[Neurology Advisor @NeuroAdvisor]

Plasma biomarkers correlate with #amyloid and tau positron emission tomography imaging measures in adults with pre-dementia stages of #AlzheimerDisease, supporting their potential utility in diagnosing and monitoring early pathology.

https://t.co/MywKB6ZKuq

[Neurology Advisor @NeuroAdvisor]

Among adults with chronic migraine and medication-overuse #headache, adding #eptinezumab to brief education improved headache burden, disability, and quality of life, supporting its use in preventive management.

https://t.co/ltQQuYG72c

[Neurology Advisor @NeuroAdvisor]

Older adults who live in closer proximity to lead-releasing industrial facilities may experience poorer cognitive performance, including worse episodic memory and global #cognition.

#ClimateAction #LeadExposure

https://t.co/C99W6rKCdI

[Neurology Advisor @NeuroAdvisor]

Poor #sleep behaviors, particularly daytime napping, short sleep duration, and sleeplessness, are significantly associated with greater #WhiteMatterHyperintensity volume in healthy middle-aged and older adults.

https://t.co/ju5vgA0BXe

[Neurology Advisor @NeuroAdvisor]

To round out our May coverage #ALSAwarenessMonth, we spoke with William B Nowell, PhD, MSW, @Regeneron, about the lived experiences of individuals with #AmyotrophicLateralSclerosis and the limitations of standard clinical metrics.

https://t.co/5xfBVLkd1J